|
CHUK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7125190154843E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.3274936705443E-12 |
| Normal-vs-Stage2 |
8.4192000004979E-07 |
| Normal-vs-Stage3 |
1.48789980336517E-10 |
| Normal-vs-Stage4 |
3.49500428598049E-11 |
| Stage1-vs-Stage2 |
6.300800E-01 |
| Stage1-vs-Stage3 |
4.760200E-01 |
| Stage1-vs-Stage4 |
8.626300E-02 |
| Stage2-vs-Stage3 |
3.901400E-01 |
| Stage2-vs-Stage4 |
9.843800E-02 |
| Stage3-vs-Stage4 |
3.204200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.50510764646606E-14 |
| Normal-vs-AfricanAmerican |
1.241220E-04 |
| Normal-vs-Asian |
2.53440000097527E-08 |
| Caucasian-vs-AfricanAmerican |
2.975200E-01 |
| Caucasian-vs-Asian |
7.962400E-01 |
| AfricanAmerican-vs-Asian |
3.131600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84297022087776E-14 |
| Normal-vs-Female |
1.00669472757886E-11 |
| Male-vs-Female |
2.798400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.83200018991181E-10 |
| Normal-vs-Age(41-60Yrs) |
1.37667655053519E-14 |
| Normal-vs-Age(61-80Yrs) |
1.16230000068995E-08 |
| Normal-vs-Age(81-100Yrs) |
1.918380E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.141800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.601800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.542600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.137220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.310600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.865400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.191200E-01 |
| Classical-VS-Follicular |
8.269400E-01 |
| Classical-VS-Other |
9.969800E-02 |
| Classical-VS-Normal |
2.47413201037716E-12 |
| Tall-VS-Follicular |
5.308400E-01 |
| Tall-VS-Other |
1.918400E-01 |
| Tall-VS-Normal |
1.76420000053135E-07 |
| Follicular-VS-Other |
1.632040E-01 |
| Follicular-VS-Normal |
2.01680000033733E-07 |
| Other-VS-Normal |
2.09359999999714E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.22299947946658E-11 |
| Normal-vs-N1 |
7.42761407934722E-12 |
| N0-vs-N1 |
1.006190E-01 |
|
|
